{
    "clinical_study": {
        "@rank": "33342", 
        "arm_group": [
            {
                "arm_group_label": "Mucosal tumors of the colon", 
                "description": "Patients who received endoscopic treatment for noninvasive mucosal tumors of the colon."
            }, 
            {
                "arm_group_label": "Nonampullary tumors of the duodenum", 
                "description": "Patients who received endoscopic treatment for noninvasive mucosal tumors of the duodenum."
            }, 
            {
                "arm_group_label": "Ampullary tumors", 
                "description": "Patients who received endoscopic treatment for noninvasive ampullary tumors."
            }
        ], 
        "brief_summary": {
            "textblock": "To evaluate clinical outcome for patients receiving treatment of suspected premalignant and\n      malignant gastrointestinal lesions at Interventional Endoscopy Services. The primary outcome\n      is curative endoscopic resection, and the secondary outcomes are complication rates, such as\n      infection, bleeding, perforation and death, and one-year survival rates."
        }, 
        "brief_title": "Clinical Outcomes of the Endoscopic Resection of Premalignant and Malignant Gastrointestinal Lesions", 
        "condition": [
            "Gastrointestinal Neoplasms", 
            "Benign Neoplasm of Intestinal Tract"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Neoplasms", 
                "Gastrointestinal Neoplasms", 
                "Digestive System Neoplasms", 
                "Intestinal Neoplasms", 
                "Precancerous Conditions", 
                "Brain Neoplasms"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients age >18 years that have been referred for endoscopic treatment of GI\n             lesions.\n\n        Exclusion Criteria:\n\n          -  Patients who do not sign informed consent\n\n          -  Patients for whom endoscopic treatment was not performed."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Patients referred to Interventional Endoscopy Services at CPMC for treatment of GI tract\n        tumors."
            }
        }, 
        "enrollment": {
            "#text": "1000", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 12, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01750619", 
            "org_study_id": "2011.090"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "December 30, 2013", 
        "location": {
            "contact": {
                "email": "kanesd@sutterhealth.org", 
                "last_name": "Steve D Kane"
            }, 
            "facility": {
                "address": {
                    "city": "San Francisco", 
                    "country": "United States", 
                    "state": "California", 
                    "zip": "94115"
                }, 
                "name": "Interventional Endoscopy Services"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "3", 
        "official_title": "Clinical Outcomes of the Endoscopic Resection of Premalignant and Malignant Gastrointestinal Lesions", 
        "overall_contact": {
            "email": "kanesd@sutterhealth.org", 
            "last_name": "Steve D Kane"
        }, 
        "overall_official": {
            "affiliation": "California Pacific Medical Center", 
            "last_name": "Kenneth F Binmoeller, M.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "January 2020", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Technical success is defined as complete resection confirmed by the endoscopic absence of adenomatous tissue after inspection with high-definition white light and narrow-band imaging.", 
            "measure": "Technical success.", 
            "safety_issue": "No", 
            "time_frame": "1 day to 3 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01750619"
        }, 
        "responsible_party": {
            "investigator_affiliation": "California Pacific Medical Center Research Institute", 
            "investigator_full_name": "Kenneth Binmoeller", 
            "investigator_title": "Interventional Endoscopy Services Program Director", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Freedom from recurrence on follow-up endoscopy with high definition white light and narrow band imaging and on mucosal biopsies of the endoscopic mucosal resection site", 
                "measure": "Short term recurrence rate", 
                "safety_issue": "No", 
                "time_frame": "Less than 1 year"
            }, 
            {
                "description": "Freedom from recurrence on follow-up endoscopy with high definition white light and narrow band imaging and on mucosal biopsies of the endoscopic mucosal resection site", 
                "measure": "Long term recurrence rate", 
                "safety_issue": "No", 
                "time_frame": "Greater than 1 year"
            }, 
            {
                "description": "Adverse events include infection, bleeding, perforation and death.", 
                "measure": "Adverse event rate", 
                "safety_issue": "Yes", 
                "time_frame": "up to 1 month post procedure."
            }
        ], 
        "source": "California Pacific Medical Center Research Institute", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "California Pacific Medical Center Research Institute", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "July 2011", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "December 2013"
    }
}